Back to top
more

Portage Biotech (PRTG)

(Delayed Data from NSDQ)

$0.19 USD

0.19
316,099

0.00 (-2.01%)

Updated Jul 23, 2024 03:57 PM ET

After-Market: $0.19 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 33% (82 out of 250)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Fiscal Year End for Portage Biotech Inc falls in the month of March.

All items in Millions except Per Share data.

3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020
Assets          
Cash & Equivalents -99,999 11 23 3 3
Receivables NA 0 0 0 0
Notes Receivable NA 0 0 0 0
Inventories NA 0 0 0 0
Other Current Assets NA 3 1 2 1
Total Current Assets NA 14 25 5 4
Net Property & Equipment NA 82 117 117 117
Investments & Advances NA 3 9 9 9
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 0 43 43 43
Deposits & Other Assets NA 1 0 0 0
Total Assets NA 99 195 175 173
Liabilities & Shareholders Equity 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020
Notes Payable NA 0 0 0 0
Accounts Payable NA 2 1 2 1
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 1 1
Total Current Liabilities NA 2 1 3 3
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 11 28 24 22
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 11 0 0 3
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 24 29 27 28
Shareholders Equity 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 219 158 131 118
Capital Surplus NA 0 0 0 0
Retained Earnings NA -160 -55 -38 -22
Other Equity NA 16 62 55 50
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 75 165 148 146
Total Liabilities & Shareholder's Equity NA 99 195 175 173
Total Common Equity 0 75 165 148 146
Shares Outstanding 17.80 16.90 13.30 12.00 NA
Book Value Per Share 0.00 4.46 12.44 12.30 0.00

Fiscal Year End for Portage Biotech Inc falls in the month of March.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents -99,999 -99,999 5 3 8
Receivables NA NA 0 0 0
Notes Receivable NA NA 0 0 0
Inventories NA NA 0 0 0
Other Current Assets NA NA 2 2 3
Total Current Assets NA NA 8 6 11
Net Property & Equipment NA NA 35 82 82
Investments & Advances NA NA 6 3 5
Other Non-Current Assets NA NA 0 0 0
Deferred Charges NA NA 0 0 0
Intangibles NA NA 0 0 0
Deposits & Other Assets NA NA 1 1 1
Total Assets NA NA 49 92 98
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable NA NA 0 0 0
Accounts Payable NA NA 3 3 3
Current Portion Long-Term Debt NA NA 0 0 0
Current Portion Capital Leases NA NA 0 0 0
Accrued Expenses NA NA 0 0 0
Income Taxes Payable NA NA 0 0 0
Other Current Liabilities NA NA 0 0 0
Total Current Liabilities NA NA 3 3 3
Mortgages NA NA 0 0 0
Deferred Taxes/Income NA NA 0 10 10
Convertible Debt NA NA 0 0 0
Long-Term Debt NA NA 0 0 0
Non-Current Capital Leases NA NA 0 0 0
Other Non-Current Liabilities NA 15 13 12
Minority Interest (Liabilities) NA NA 0 0 0
Total Liabilities NA NA 18 25 26
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock NA NA 0 0 0
Common Stock (Par) NA NA 219 219 219
Capital Surplus NA NA 0 0 0
Retained Earnings NA NA -210 -171 -166
Other Equity NA NA 22 18 19
Treasury Stock NA NA 0 0 0
Total Shareholder's Equity NA NA 31 67 73
Total Liabilities & Shareholder's Equity NA NA 49 92 98
Total Common Equity 0 0 31 67 73
Shares Outstanding 17.80 17.80 17.80 17.80 16.90
Book Value Per Share 0.00 0.00 1.76 3.76 4.30